SonoSite Inc. Introduces the New BioZ Cardio Profile for Hemodynamic Monitoring in the Anesthesia Suite

BOTHELL, Wash.--(BUSINESS WIRE)--SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient’s hemodynamic profile in the hospital. Pioneered by NASA in the 1960’s, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.

MORE ON THIS TOPIC